Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes

Oncogene

Volumn 24, Issue 51, 2005, Pages 7619-7623

  Hut, Henderika M J ^a   Rembacz, Krzysztof P ^a   Van Waarde, Maria A W H ^a   Lemstra, Willy ^a   Van Cappellen, Wiggert A ^b   Kampinga, Harm H ^a   Sibon, Ody C M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

BF3; BRCA1; Cancer; Centrosomes; EGFP BRCA1

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR; HYBRID PROTEIN;

ARTICLE; CANCER; CARCINOGENESIS; CELL; CELL CYCLE G2 PHASE; CENTROSOME; CONTROLLED STUDY; DNA REPAIR; GENETIC DAMAGE; HUMAN; HUMAN CELL; HYPOTHESIS; MITOSIS; ONCOGENE; PRIORITY JOURNAL;

ANTIBODIES; BRCA1 PROTEIN; CELL CYCLE; CENTROSOME; DNA DAMAGE; DNA REPAIR; HUMANS; MITOSIS; MUTATION; NEOPLASMS;

EID: 27844555327     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208859     Document Type: Article

References (22)

1. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP and Brinkley BR. (1995). J. Cell Biol., 130, 105-115.
2. Borel F, Lohez OD, Lacroix FB and Margolis RL. (2002). Proc. Natl. Acad. Sci. USA, 99, 9819-9824.
3. Deng CX. (2002). Oncogene, 21, 6222-6227.
4. Dodson H, Bourke E, Jeffers LJ, Vagnarelli P, Sonoda E, Takeda S, Earnshaw WC, Merdes A and Morrison C. (2004). EMBO J., 23, 3864-3873.
5. Doxsey S. (2002). Mol. Cell 10, 439-440.
6. Fisk HA, Mattison CP and Winey M. (2002). Curr. Opin. Cell Biol., 14, 700-705.
7. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM and Piwnica-Worms H. (2000). J. Biol. Chem., 275, 5600-5605.
8. Hsu LC and White RL. (1998). Proc. Natl. Acad. Sci. USA, 95, 12983-12988.
9. Hsu LC, Doan TP and White RL. (2001). Cancer Res., 61, 7713-7718.
10. Hut HM, Lemstra W, Blaauw EH, Van Cappellen GW, Kampinga HH and Sibon OC. (2003). Mol. Biol. Cell, 14, 1993-2004.
11. Johannsson OT, Staff S, Vallon-Christersson J, Kytola S, Gudjonsson T, Rennstam K, Hedenfalk IA, Adeyinka A, Kjellen E, Wennerberg J, Baldetorp B, Petersen OW, Olsson H, Oredsson S, Isola J and Borg A. (2003). Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation. Lab. Invest., 84, 387-396.
12. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL. (2002). Proc. Natl. Acad. Sci. USA, 99, 1978-1983.
13. Marx J. (2001). Science, 292, 426-429.
14. Meraldi P, Honda R and Nigg EA. (2002). EMBO J., 21, 483-492.
15. Moynahan ME, Chiu JW, Koller BH and Jasin M. (1999). Mol. Cell, 4, 511-518.
16. Rieder CL, Faruki S and Khodjakov A. (2001). Trends Cell Biol, 11, 413-419.
17. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J and Livingston DM. (1997). Cell, 90, 425-435.
18. Sibon OC, Kelkar A, Lemstra W and Theurkauf WE. (2000). Nat. Cell Biol., 2, 90-95.
19. Takada S, Kelkar A and Theurkauf WE. (2003). Cell, 113, 87-99.
20. Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL. (1997). Mol. Cell Biol., 17, 444-452.
21. Wong C and Stearns T. (2003). Nat. Cell Biol., 5, 539-544.
22. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T and Deng CX. (1999). Mol. Cell, 3, 389-395.